SAN

79.13

-1.37%↓

UCB

274.1

-0.22%↓

SHL.DE

37.75

+0.05%↑

ARGX

679.4

-0.21%↓

VIE

34.5

-1.4%↓

SAN

79.13

-1.37%↓

UCB

274.1

-0.22%↓

SHL.DE

37.75

+0.05%↑

ARGX

679.4

-0.21%↓

VIE

34.5

-1.4%↓

SAN

79.13

-1.37%↓

UCB

274.1

-0.22%↓

SHL.DE

37.75

+0.05%↑

ARGX

679.4

-0.21%↓

VIE

34.5

-1.4%↓

SAN

79.13

-1.37%↓

UCB

274.1

-0.22%↓

SHL.DE

37.75

+0.05%↑

ARGX

679.4

-0.21%↓

VIE

34.5

-1.4%↓

SAN

79.13

-1.37%↓

UCB

274.1

-0.22%↓

SHL.DE

37.75

+0.05%↑

ARGX

679.4

-0.21%↓

VIE

34.5

-1.4%↓

Search

Vetoquinol SA

Închisă

SectorSănătate

78.7 -1.13

Rezumat

Modificarea prețului

24h

Curent

Minim

77.5

Maxim

79.6

Indicatori cheie

By Trading Economics

Venit

25M

Vânzări

10M

268M

P/E

Medie Sector

15.373

66.418

Marjă de profit

9.734

Angajați

2,497

EBITDA

252M

301M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+37.16% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

-7.1M

928M

Deschiderea anterioară

79.83

Închiderea anterioară

78.7

Sentimentul știrilor

By Acuity

50%

50%

154 / 348 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Vetoquinol SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 apr. 2026, 23:25 UTC

Evenimente importante

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13 apr. 2026, 22:45 UTC

Evenimente importante

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13 apr. 2026, 18:03 UTC

Câștiguri

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13 apr. 2026, 23:58 UTC

Câștiguri

Review & Preview: Earnings Time -- Barrons.com

13 apr. 2026, 23:49 UTC

Market Talk

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13 apr. 2026, 23:33 UTC

Market Talk
Evenimente importante

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13 apr. 2026, 23:20 UTC

Market Talk

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13 apr. 2026, 23:01 UTC

Câștiguri

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13 apr. 2026, 23:01 UTC

Câștiguri

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13 apr. 2026, 23:01 UTC

Câștiguri

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13 apr. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13 apr. 2026, 21:53 UTC

Câștiguri

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13 apr. 2026, 21:53 UTC

Câștiguri

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13 apr. 2026, 21:53 UTC

Câștiguri

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13 apr. 2026, 21:53 UTC

Câștiguri

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13 apr. 2026, 21:26 UTC

Evenimente importante

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13 apr. 2026, 21:23 UTC

Câștiguri

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13 apr. 2026, 21:16 UTC

Câștiguri

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13 apr. 2026, 20:50 UTC

Market Talk
Evenimente importante

Basic Materials Roundup: Market Talk

13 apr. 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

13 apr. 2026, 20:34 UTC

Câștiguri

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13 apr. 2026, 20:34 UTC

Câștiguri

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13 apr. 2026, 20:34 UTC

Câștiguri

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13 apr. 2026, 19:59 UTC

Market Talk

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13 apr. 2026, 19:50 UTC

Market Talk
Evenimente importante

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13 apr. 2026, 19:27 UTC

Market Talk
Evenimente importante

Correction to Precious Metals Market Talk on April 9

13 apr. 2026, 19:14 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13 apr. 2026, 18:59 UTC

Market Talk
Evenimente importante

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13 apr. 2026, 18:59 UTC

Market Talk
Evenimente importante

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13 apr. 2026, 18:43 UTC

Market Talk

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Comparație

Modificare preț

Vetoquinol SA Așteptări

Obiectiv de preț

By TipRanks

37.16% sus

Prognoză pe 12 luni

Medie 110 EUR  37.16%

Maxim 110 EUR

Minim 110 EUR

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVetoquinol SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

72.6 / 75.1Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

154 / 348 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat